ArticleFrontiers in immunology2022

Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer.

Silvia Ghione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.